-
Why These Are Hot: Seventy Seven Energy (NYSE:SSE), Intercept Pharmaceuticals (NASDAQ:ICPT), Rogers Communications, Starwood Hotels & Resorts Worldwide (NYSE:HOT), MNST
Seventy Seven Energy Inc. (NYSE:SSE) has scheduled to release its 2014 fourth quarter operational update and financial results before market open on Monday, March 2, 2015. On Monday shares of Seventy Seven Energy Inc. (NYSE:SSE) closed at $4.23. Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) announced after the close Thursday that its investigational product obeticholic acid has received…
-
Premarket Gainers to Watch: Books-A-Million Inc. (NASDAQ:BAMM), Intercept Pharmaceuticals (NASDAQ:ICPT), ImmunoGen (NASDAQ:IMGN), Performant Financial Corporation (NASDAQ:PFMT), Synaptics Inc. (NASDAQ:SYNA)
Books-A-Million Inc. (NASDAQ:BAMM) announced Thursday that it has received a non-binding proposal from Clyde Anderson, Executive Chairman of the Company, on behalf of the Anderson family, to acquire certain outstanding shares of the common stock of Books-A-Million, Inc., at a cash purchase price of $2.75 per share. On Thursday shares of Books-A-Million Inc. (NASDAQ:BAMM) closed…
-
Notable Moves: Biogen Idec Inc. (NASDAQ:BIIB), JetBlue Airways Corporation (NASDAQ:JBLU), IntraLinks Holdings (NYSE:IL), Intercept Pharmaceuticals (NASDAQ:ICPT), On Assignment Inc. (NYSE:ASGN)
Biogen Idec Inc. (NASDAQ:BIIB) is scheduled to announce its fourth quarter earnings before the market opens Wednesday. Net income of $3.77 a share is the consensus of analysts surveyed by Thomson Reuters, compared with $2.34 reported a year earlier. On Monday shares of Biogen Idec Inc. (NASDAQ:BIIB) closed at $362.44. Company’s sales growth for last…
-
Don’t Miss These Stocks: Solazyme (NASDAQ:SZYM), Novatel Wireless Inc. (NASDAQ:MIFI), Atmel Corporation (NASDAQ:ATML), Intercept Pharmaceuticals (NASDAQ:ICPT), JB Hunt Transport Services (NASDAQ:JBHT)
On 15 January Solazyme, Inc. (NASDAQ:SZYM) announced that the US Food and Drug Administration (FDA) has issued a favorable response to Solazyme’s notification concluding that Whole Algal Protein is Generally Recognized as Safe (GRAS) as an ingredient in food and beverage products. On Friday shares of Solazyme, Inc. (NASDAQ:SZYM) closed at $2.31. Company’s sales growth…
-
Traders Should Watch: MGM Resorts International (NYSE:MGM), Intercept Pharmaceuticals (NASDAQ:ICPT), Calamos Asset Management Inc. (NASDAQ:CLMS), Bio-Reference Laboratories (NASDAQ:BRLI), Roundy’s (NYSE:RNDY)
MGM Resorts International (NYSE:MGM) said that it was again named one of the 40 best companies in the nation for diversity by Black Enterprise magazine. On Friday shares of MGM Resorts International (NYSE:MGM) closed at $20.00. Company’s sales growth for last 5 years was 6.40% and EPS growth for next 5 years is recorded as…
-
Market Movers: Intercept Pharmaceuticals (NASDAQ:ICPT), Facebook Inc (NASDAQ:FB), Books-A-Million (NASDAQ:BAMM), International Business Machines Corporation (NYSE:IBM), CEVA Inc. (NASDAQ:CEVA)
“We are hijacking the natural food signal in the body to trick it into burning calories and lowering systemic glucose levels. Other farnesoid X receptor-targeted drugs are readily absorbed via the gut into circulation. Fexaramine is a unique class of drugs that are not absorbed into the circulation and therefore only activates its molecular target,…
-
Stocks in Focus: BlackBerry Ltd (NASDAQ:BBRY), Eldorado Gold Corporation (NYSE:EGO), Intercept Pharmaceuticals (NASDAQ:ICPT), PetSmart (NASDAQ:PETM), BioTime (NYSEMKT: BTX)
On 5 January BlackBerry Ltd (NASDAQ:BBRY) has officially abandoned Adobe Flash in their main internet browser for all Blackberry 10 enabled smartphones. This move was prompted by Adobe ceasing active support for the platform as the industry seems to have embraced HTML5. On Tuesday shares of BlackBerry Ltd (NASDAQ:BBRY) closed at $10.03. Company’s sales growth…
-
Best Stocks: Cypress Semiconductor (NASDAQ:CY), Marvell Technology Group (NASDAQ:MRVL), Agios Pharmaceuticals (NASDAQ:AGIO), Fred’s (NASDAQ:FRED), Intercept Pharmaceuticals (NASDAQ:ICPT)
Shares of Cypress Semiconductor (NASDAQ:CY) were the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 20,925,007 shares, an increase of 97.3% from the November 28th total of 10,605,527 shares, Stock Ratings Network reports. On Friday shares of Cypress Semiconductor Corporation (NASDAQ:CY)…